Volume 65, Issue 5, Pages (May 2004)

Slides:



Advertisements
Similar presentations
Figure 3. CSE increases the production of IL-8 in A549 cells
Advertisements

Volume 65, Issue 5, Pages (May 2004)
Volume 67, Issue 3, Pages (March 2005)
Myoung J. Kang, Alistair Ingram, Hao Ly, Kerri Thai, James W. Scholey 
Volume 59, Issue 5, Pages (May 2001)
Volume 66, Issue 2, Pages (August 2004)
Volume 59, Issue 4, Pages (April 2001)
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation  Catherine W. Cheung, David A. Vesey,
Volume 64, Issue 3, Pages (September 2003)
Volume 68, Issue 5, Pages (November 2005)
Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells  W. Qi, X. Chen, S. Twigg, T.S. Polhill,
Volume 78, Issue 3, Pages (August 2010)
Ravinder S. Chana, David C. Wheeler  Kidney International 
Volume 67, Issue 3, Pages (March 2005)
New Vitamin D analogs and changing therapeutic paradigms
Volume 63, Issue 2, Pages (February 2003)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells  Guillermo Villegas, Bäerbel Lange-Sperandio,
Yiping Wang, Yuet-Ching Tay, David C.H. Harris  Kidney International 
Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation1  Dr Xiong Z. Ruan, Zac Varghese, Stephen.
Volume 56, Issue 1, Pages (July 1999)
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Volume 74, Issue 7, Pages (October 2008)
Volume 65, Issue 4, Pages (April 2004)
TGF-β isoforms in renal fibrogenesis
Volume 68, Issue 3, Pages (September 2005)
Volume 59, Issue 1, Pages (January 2001)
Volume 67, Issue 4, Pages (April 2005)
Volume 64, Issue 5, Pages (November 2003)
Volume 59, Issue 5, Pages (May 2001)
Enyu Imai, Hideaki Nakajima, Jun-Ya Kaimori  Kidney International 
Volume 62, Issue 3, Pages (September 2002)
Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells1  Gunter Wolf, Regine Schroeder, Fuad N.
Volume 68, Issue 1, Pages (July 2005)
Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cells  Mimi Sohn, Yan Tan, Richard L. Klein, Ayad.
Volume 78, Issue 2, Pages (July 2010)
Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy  S.C.W. Tang, J.C.K.
Protein uptake disturbs collagen homeostasis in proximal tubule-derived cells  Verena Wohlfarth, Karina Drumm, Sigrid Mildenberger, Ruth Freudinger, Michael.
Volume 59, Issue 5, Pages (May 2001)
Volume 63, Issue 5, Pages (May 2003)
Volume 68, Issue 2, Pages (August 2005)
The need for reliable serum parathyroid hormone measurements
Volume 57, Issue 5, Pages (May 2000)
Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathy  Stuart Jones, Suzanne Jones, Aled Owain.
The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation  Catherine W. Cheung, David A. Vesey,
Volume 73, Issue 5, Pages (March 2008)
Volume 56, Issue 1, Pages (July 1999)
Volume 65, Issue 2, Pages (February 2004)
Volume 53, Issue 6, Pages (June 1998)
Macrophages and hypoxia in human chronic kidney disease
Volume 65, Issue 5, Pages (May 2004)
Volume 58, Issue 6, Pages (December 2000)
Volume 70, Issue 6, Pages (September 2006)
Volume 67, Issue 4, Pages (April 2005)
Lipoprotein-stimulated mesangial cell proliferation and gene expression are regulated by lipoprotein lipase1  Frazier T. Stevenson, Gregory C. Shearer,
Volume 58, Issue 2, Pages (August 2000)
High glucose–induced PKC activation mediates TGF-β1 and fibronectin synthesis by peritoneal mesothelial cells  Hunjoo Ha, Mi Ra Yu, Hi Bahl Lee  Kidney.
Volume 60, Issue 5, Pages (November 2001)
Ken Inoki, Masakazu Haneda, Shiro Maeda, Daisuke Koya, Ryuichi Kikkawa 
Volume 61, Issue 5, Pages (May 2002)
Volume 64, Issue 6, Pages (December 2003)
Volume 67, Issue 6, Pages (June 2005)
NODding off in acute kidney injury with progranulin?
Volume 60, Issue 1, Pages (July 2001)
Renin–angiotensin system blockade and diabetes: moving the adipose organ from the periphery to the center  Oliver Lenz, Alessia Fornoni  Kidney International 
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Volume 77, Issue 5, Pages (March 2010)
Volume 62, Issue 5, Pages (November 2002)
Volume 128, Issue 4, Pages (April 2005)
Presentation transcript:

Volume 65, Issue 5, Pages 1647-1653 (May 2004) Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses  Stephen Zafiriou, Scott R. Stanners, Tania S. Polhill, Philip Poronnik, Carol A. Pollock  Kidney International  Volume 65, Issue 5, Pages 1647-1653 (May 2004) DOI: 10.1111/j.1523-1755.2004.00574.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Peroxisome proliferator-activated receptor gamma (PPARγ) is expressed in opossum kidney cells. Western Blot of opossum kidney cell lysate showing that PPARγ is expressed in opossum kidney cells and has a molecular weight of ∼50 kD. Kidney International 2004 65, 1647-1653DOI: (10.1111/j.1523-1755.2004.00574.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Growth in opossum kidney cells exposed to pioglitazone with and without low-density lipoprotein (LDL) and/or albumin. Cell protein (A) and cell number (B) in opossum kidney cells exposed to the defined treatments for 24hours. Symbols are: (▪) 5mmol/L glucose (5Glc); 5mmol/L glucose with pioglitazone 10 μmol/L; LDL 100, LDL 100 μg/mL; albumin, albumin 1mg/mL; LDL + Alb, LDL 100 μg/mL + albumin 1mg/mL. Kidney International 2004 65, 1647-1653DOI: (10.1111/j.1523-1755.2004.00574.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Albumin uptake in opossum kidney cells. (A) Following 24hours' exposure to different concentrations of pioglitazone (0.1 to 10 μmol/L), opossum kidney cells were incubated with Texas Red–bovine serum albumin (BSA) (100 μg/mL) for 2hours, after which time the intracellular Texas Red–BSA uptake was measured and corrected for cell protein. Results are standardized against control conditions (opossum kidney cells in 5mmol/L glucose). (B) Albumin uptake in opossum kidney cells exposed to pioglitazone with and without low-density lipoprotein (LDL) and/or albumin. Following 24hours' exposure to the defined treatments, opossum kidney cells were incubated with Texas Red–BSA (100 μg/mL) for 2hours, after which time the intracellular Texas Red–BSA uptake was measured and corrected for cell protein. Symbols are: (▪) 5mmol/L glucose (5Glc); 5mmol/L glucose with pioglitazone 10 μmol/L; LDL 100, LDL 100 μg/mL; albumin, albumin 1mg/mL; LDL + Alb, LDL 100 μg/mL + albumin 1mg/mL. Kidney International 2004 65, 1647-1653DOI: (10.1111/j.1523-1755.2004.00574.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 4 Transforming growth factor-β1 (TGF-β1) secretion in opossum kidney cells exposed to pioglitazone with and without low-density lipoprotein (LDL) and/or albumin. Active TGF-β1 levels were measured by enzyme-linked immunosorbent assay (ELISA) in media conditioned by opossum kidney cells exposed to the defined experimental treatments for 24hours. Symbols are: (▪) 5mmol/L glucose (5Glc); 5mmol/L glucose with pioglitazone 10 μmol/L; LDL 100, LDL 100 μg/mL; albumin, albumin 1mg/mL; LDL + Alb, LDL 100 μg/mL + albumin 1mg/mL. #P < 0.05 for LDL 100 μg/mL vs. LDL 100 μg/mL with pioglitazone 10 μmol/L. Kidney International 2004 65, 1647-1653DOI: (10.1111/j.1523-1755.2004.00574.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 5 Monocyte chemoattractant protein-1 (MCP-1) secretion in opossum kidney cells exposed to pioglitazone with and without low-density lipoprotein (LDL) and/or albumin. MCP-1 levels were measured by enzyme-linked immunosorbent assay (ELISA) in media conditioned by opossum kidney cells exposed to the defined experimental treatments for 24hours. Symbols are: (▪) 5mmol/L glucose (5Glc); 5mmol/L glucose with pioglitazone 10 μmol/L; LDL 100, LDL 100 μg/mL; albumin, albumin 1mg/mL; LDL + Alb, LDL 100 μg/mL + albumin 1mg/mL. #P < 0.05 for LDL 100 μg/mL vs. LDL 100 μg/mL with pioglitazone 10 μmol/L. Kidney International 2004 65, 1647-1653DOI: (10.1111/j.1523-1755.2004.00574.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 6 Nuclear factor-κB (NFκB)-secreted alkaline phosphatase (SEAP) activity in opossum kidney cells exposed to pioglitazone with and without low-density lipoprotein (LDL) and/or albumin. NF-κB–specific reporter gene assay. SEAP expression of opossum kidney cells exposed to the defined treatments for 24hours. Symbols are: (▪) 5mmol/L glucose (5Glc); 5mmol/L glucose with pioglitazone 10 μmol/L; LDL 100, LDL 100 μg/mL; albumin, albumin 1mg/mL; LDL + Alb, LDL 100 μg/mL + albumin 1mg/mL. Kidney International 2004 65, 1647-1653DOI: (10.1111/j.1523-1755.2004.00574.x) Copyright © 2004 International Society of Nephrology Terms and Conditions